BHCM
CLB icon

Brevan Howard Capital Management’s Core Laboratories CLB Stock Holding History

Brevan Howard Capital Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-11,187
Closed -$138K – 1869
2025
Q3 		$138K Sell
11,187
-5,183
-32% -$60.8K ﹤0.01% 1831
2025
Q2 		$189K Buy
+16,370
New +$194K ﹤0.01% 1723

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Brevan Howard Capital Management's CLB Position: Q4 2025 in Review

Brevan Howard Capital Management sold out of Core Laboratories (CLB) in Q4 2025, closing a stake of 11,187 shares — an estimated $138K sold.

Brevan Howard Capital Management first reported a position in CLB in Q2 2025 and held it in 2 quarters. The position peaked at $189K in Q2 2025. 187 funds tracked by Wall St. Rank hold CLB as of Q4 2025.

  • Brevan Howard Capital Management reported no remaining Core Laboratories position as of Q4 2025 after selling out during the quarter.
  • Brevan Howard Capital Management sold 11,187 Core Laboratories shares in Q4 2025, an estimated $138K.
  • Brevan Howard Capital Management first reported a position in Core Laboratories in Q2 2025 and held it in 2 quarters.
  • Brevan Howard Capital Management's Core Laboratories position peaked at $189K in Q2 2025.
  • 187 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2025.

Based on Brevan Howard Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.